APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ceftriaxone Sodium

Ceftriaxone sodium is a cephalosporin antibiotic.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Ceftriaxone sodium is a cephalosporin antibiotic.

Selected research

Industry Growth & Trends

Global Ceftriaxone Sodium Industry Growth and Trends Forecast to 2032

28 December 2025100 pages

Choose your research edition.

Industry ResearchCeftriaxone Sodium Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceftriaxone Sodium Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Ceftriaxone Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceftriaxone Sodium Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceftriaxone Sodium Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Ceftriaxone sodium is a cephalosporin antibiotic.

There are three kinds of Ceftriaxone Sodium, which are ChP, USP and EP. ChP hold the largest share of the Ceftriaxone Sodium market, with a sales market share nearly 74% in 2019.

Ceftriaxone Sodium is used in Single Injection and Compound Injection. The most proportion of Ceftriaxone Sodium is used in Single Injection, and the market share in 2019 is about 96%.

Read the full market overview

Asia-Pacific is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 12%.

For the production, China and India are the mainly manufactured base.

Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, etc. are the leader of the industry, and top 5 players hold about 50% revenue market share.

Report Scope

This report provides a structured, data-driven view of the global Ceftriaxone Sodium market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ceftriaxone Sodium market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ceftriaxone Sodium market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ceftriaxone Sodium.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ceftriaxone Sodium market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ceftriaxone Sodium Market by Company

Shandong Ruiying

Qilu Antibiotics

Nectar Lifesciences

Kelun

United Laboratories

Aurobindo Pharma

Orchid Pharma

Medya Pharma

REYOUNG

LKPC

ACS Dobfar

NCPC

Dawnrays

Kopran

Ceftriaxone Sodium Segment by Type

ChP

USP

EP

Ceftriaxone Sodium Segment by Application

Single Injection

Compound Injection

Ceftriaxone Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceftriaxone Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceftriaxone Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceftriaxone Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ceftriaxone Sodium manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ceftriaxone Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ChP Table 2. Major Company of USP Table 3. Major Company of EP Table 4. Global Ceftriaxone Sodium Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Ceftriaxone Sodium Sales by Type (2021-2026) & (MT) Table 6. Global Ceftriaxone Sodium Sales Market Share in Volume by Type (2021-2026) Table 7. Global Ceftriaxone Sodium Sales by Type (2021-2026) & (US$ Million) Table 8. Global Ceftriaxone Sodium Sales Market Share in Value by Type (2021-2026) Table 9. Global Ceftriaxone Sodium Price by Type (2021-2026) & (USD/Kg) Table 10. Global Ceftriaxone Sodium Sales by Type (2027-2032) & (MT) Table 11. Global Ceftriaxone Sodium Sales Market Share in Volume by Type (2027-2032) Table 12. Global Ceftriaxone Sodium Sales by Type (2027-2032) & (US$ Million) Table 13. Global Ceftriaxone Sodium Sales Market Share in Value by Type (2027-2032) Table 14. Global Ceftriaxone Sodium Price by Type (2027-2032) & (USD/Kg) Table 15. North America Ceftriaxone Sodium Sales by Type (2021-2026) & (MT) Table 16. North America Ceftriaxone Sodium Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Ceftriaxone Sodium Sales by Type (2021-2026) & (MT) Table 18. Europe Ceftriaxone Sodium Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Ceftriaxone Sodium Sales by Type (2021-2026) & (MT) Table 20. Asia-Pacific Ceftriaxone Sodium Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Ceftriaxone Sodium Sales by Type (2021-2026) & (MT) Table 22. Latin America Ceftriaxone Sodium Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Ceftriaxone Sodium Sales by Type (2021-2026) & (MT) Table 24. Middle East and Africa Ceftriaxone Sodium Sales by Type (2021-2026) & (US$ Million) Table 25. Ceftriaxone Sodium Industry Trends Table 26. Ceftriaxone Sodium Industry Drivers Table 27. Ceftriaxone Sodium Industry Opportunities and Challenges Table 28. Ceftriaxone Sodium Industry Restraints Table 29. Global Ceftriaxone Sodium Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Ceftriaxone Sodium Revenue Market Share by Company (2021-2026) Table 31. Global Ceftriaxone Sodium Sales by Company (2021-2026) & (MT) Table 32. Global Ceftriaxone Sodium Sales Share by Company (2021-2026) Table 33. Global Ceftriaxone Sodium Market Price by Company (2021-2026) & (USD/Kg) Table 34. Global Ceftriaxone Sodium Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Ceftriaxone Sodium Major Company Production Sites and Headquarters Table 36. Global Ceftriaxone Sodium Company, Product Type & Application Table 37. Global Ceftriaxone Sodium Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Ceftriaxone Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Ceftriaxone Sodium Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Ceftriaxone Sodium Sales by Region (2021-2026) & (MT) Table 42. Global Ceftriaxone Sodium Sales Market Share in Volume by Region (2021-2026) Table 43. Global Ceftriaxone Sodium Sales by Region (2021-2026) & (US$ Million) Table 44. Global Ceftriaxone Sodium Sales Market Share in Value by Region (2021-2026) Table 45. Global Ceftriaxone Sodium Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 46. Global Ceftriaxone Sodium Sales by Region (2027-2032) & (MT) Table 47. Global Ceftriaxone Sodium Sales Market Share in Volume by Region (2027-2032) Table 48. Global Ceftriaxone Sodium Sales by Region (2027-2032) & (US$ Million) Table 49. Global Ceftriaxone Sodium Sales Market Share in Value by Region (2027-2032) Table 50. Global Ceftriaxone Sodium Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 51. Global Ceftriaxone Sodium Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Ceftriaxone Sodium Sales by Application (2021-2026) & (MT) Table 53. Global Ceftriaxone Sodium Sales Market Share in Volume by Application (2021-2026) Table 54. Global Ceftriaxone Sodium Sales by Application (2021-2026) & (US$ Million) Table 55. Global Ceftriaxone Sodium Sales Market Share in Value by Application (2021-2026) Table 56. Global Ceftriaxone Sodium Price by Application (2021-2026) & (USD/Kg) Table 57. Global Ceftriaxone Sodium Sales by Application (2027-2032) & (MT) Table 58. Global Ceftriaxone Sodium Sales Market Share in Volume by Application (2027-2032) Table 59. Global Ceftriaxone Sodium Sales by Application (2027-2032) & (US$ Million) Table 60. Global Ceftriaxone Sodium Sales Market Share in Value by Application (2027-2032) Table 61. Global Ceftriaxone Sodium Price by Application (2027-2032) & (USD/Kg) Table 62. North America Ceftriaxone Sodium Sales by Application (2021-2026) & (MT) Table 63. North America Ceftriaxone Sodium Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Ceftriaxone Sodium Sales by Application (2021-2026) & (MT) Table 65. Europe Ceftriaxone Sodium Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Ceftriaxone Sodium Sales by Application (2021-2026) & (MT) Table 67. Asia-Pacific Ceftriaxone Sodium Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Ceftriaxone Sodium Sales by Application (2021-2026) & (MT) Table 69. Latin America Ceftriaxone Sodium Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Ceftriaxone Sodium Sales by Application (2021-2026) & (MT) Table 71. Middle East and Africa Ceftriaxone Sodium Sales by Application (2021-2026) & (US$ Million) Table 72. Shandong Ruiying Company Information Table 73. Shandong Ruiying Business Overview Table 74. Shandong Ruiying Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 75. Shandong Ruiying Ceftriaxone Sodium Product Portfolio Table 76. Shandong Ruiying Recent Development Table 77. Qilu Antibiotics Company Information Table 78. Qilu Antibiotics Business Overview Table 79. Qilu Antibiotics Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 80. Qilu Antibiotics Ceftriaxone Sodium Product Portfolio Table 81. Qilu Antibiotics Recent Development Table 82. Nectar Lifesciences Company Information Table 83. Nectar Lifesciences Business Overview Table 84. Nectar Lifesciences Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 85. Nectar Lifesciences Ceftriaxone Sodium Product Portfolio Table 86. Nectar Lifesciences Recent Development Table 87. Kelun Company Information Table 88. Kelun Business Overview Table 89. Kelun Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 90. Kelun Ceftriaxone Sodium Product Portfolio Table 91. Kelun Recent Development Table 92. United Laboratories Company Information Table 93. United Laboratories Business Overview Table 94. United Laboratories Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 95. United Laboratories Ceftriaxone Sodium Product Portfolio Table 96. United Laboratories Recent Development Table 97. Aurobindo Pharma Company Information Table 98. Aurobindo Pharma Business Overview Table 99. Aurobindo Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 100. Aurobindo Pharma Ceftriaxone Sodium Product Portfolio Table 101. Aurobindo Pharma Recent Development Table 102. Orchid Pharma Company Information Table 103. Orchid Pharma Business Overview Table 104. Orchid Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 105. Orchid Pharma Ceftriaxone Sodium Product Portfolio Table 106. Orchid Pharma Recent Development Table 107. Medya Pharma Company Information Table 108. Medya Pharma Business Overview Table 109. Medya Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 110. Medya Pharma Ceftriaxone Sodium Product Portfolio Table 111. Medya Pharma Recent Development Table 112. REYOUNG Company Information Table 113. REYOUNG Business Overview Table 114. REYOUNG Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 115. REYOUNG Ceftriaxone Sodium Product Portfolio Table 116. REYOUNG Recent Development Table 117. LKPC Company Information Table 118. LKPC Business Overview Table 119. LKPC Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 120. LKPC Ceftriaxone Sodium Product Portfolio Table 121. LKPC Recent Development Table 122. ACS Dobfar Company Information Table 123. ACS Dobfar Business Overview Table 124. ACS Dobfar Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 125. ACS Dobfar Ceftriaxone Sodium Product Portfolio Table 126. ACS Dobfar Recent Development Table 127. NCPC Company Information Table 128. NCPC Business Overview Table 129. NCPC Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 130. NCPC Ceftriaxone Sodium Product Portfolio Table 131. NCPC Recent Development Table 132. Dawnrays Company Information Table 133. Dawnrays Business Overview Table 134. Dawnrays Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 135. Dawnrays Ceftriaxone Sodium Product Portfolio Table 136. Dawnrays Recent Development Table 137. Kopran Company Information Table 138. Kopran Business Overview Table 139. Kopran Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 140. Kopran Ceftriaxone Sodium Product Portfolio Table 141. Kopran Recent Development Table 142. North America Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 143. North America Ceftriaxone Sodium Sales by Country (2021-2026) & (MT) Table 144. North America Ceftriaxone Sodium Sales Market Share by Country (2021-2026) Table 145. North America Ceftriaxone Sodium Sales Forecast by Country (2027-2032) & (MT) Table 146. North America Ceftriaxone Sodium Sales Market Share Forecast by Country (2027-2032) Table 147. North America Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Ceftriaxone Sodium Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Ceftriaxone Sodium Market Share by Country (2021-2026) Table 150. North America Ceftriaxone Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Ceftriaxone Sodium Market Share Forecast by Country (2027-2032) Table 152. Europe Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 153. Europe Ceftriaxone Sodium Sales by Country (2021-2026) & (MT) Table 154. Europe Ceftriaxone Sodium Sales Market Share by Country (2021-2026) Table 155. Europe Ceftriaxone Sodium Sales Forecast by Country (2027-2032) & (MT) Table 156. Europe Ceftriaxone Sodium Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Ceftriaxone Sodium Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Ceftriaxone Sodium Market Share by Country (2021-2026) Table 160. Europe Ceftriaxone Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Ceftriaxone Sodium Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Ceftriaxone Sodium Sales by Country (2021-2026) & (MT) Table 164. Asia-Pacific Ceftriaxone Sodium Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Ceftriaxone Sodium Sales Forecast by Country (2027-2032) & (MT) Table 166. Asia-Pacific Ceftriaxone Sodium Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Ceftriaxone Sodium Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Ceftriaxone Sodium Market Share by Country (2021-2026) Table 170. Asia-Pacific Ceftriaxone Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Ceftriaxone Sodium Market Share Forecast by Country (2027-2032) Table 172. Latin America Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 173. Latin America Ceftriaxone Sodium Sales by Country (2021-2026) & (MT) Table 174. Latin America Ceftriaxone Sodium Sales Market Share by Country (2021-2026) Table 175. Latin America Ceftriaxone Sodium Sales Forecast by Country (2027-2032) & (MT) Table 176. Latin America Ceftriaxone Sodium Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Ceftriaxone Sodium Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Ceftriaxone Sodium Market Share by Country (2021-2026) Table 180. Latin America Ceftriaxone Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Ceftriaxone Sodium Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Ceftriaxone Sodium Sales by Country (2021-2026) & (MT) Table 184. Middle East and Africa Ceftriaxone Sodium Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Ceftriaxone Sodium Sales Forecast by Country (2027-2032) & (MT) Table 186. Middle East and Africa Ceftriaxone Sodium Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Ceftriaxone Sodium Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Ceftriaxone Sodium Market Share by Country (2021-2026) Table 190. Middle East and Africa Ceftriaxone Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Ceftriaxone Sodium Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Ceftriaxone Sodium Distributors List Table 195. Ceftriaxone Sodium Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Ceftriaxone Sodium Image Figure 2. Global Ceftriaxone Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceftriaxone Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Ceftriaxone Sodium Sales (2021-2032) & (MT) Figure 5. ChP Image Figure 6. Global ChP Sales YoY Growth (2021-2032) & (MT) Figure 7. USP Image Figure 8. Global USP Sales YoY Growth (2021-2032) & (MT) Figure 9. EP Image Figure 10. Global EP Sales YoY Growth (2021-2032) & (MT) Figure 11. Global Ceftriaxone Sodium Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Ceftriaxone Sodium Market Share by Type 2025 VS 2032 Figure 13. North America Ceftriaxone Sodium Sales Market Share in Volume by Type in 2025 Figure 14. North America Ceftriaxone Sodium Sales Market Share in Value by Type in 2025 Figure 15. Europe Ceftriaxone Sodium Sales Market Share in Volume by Type in 2025 Figure 16. Europe Ceftriaxone Sodium Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Ceftriaxone Sodium Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Ceftriaxone Sodium Sales Market Share in Value by Type in 2025 Figure 19. Latin America Ceftriaxone Sodium Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Ceftriaxone Sodium Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Ceftriaxone Sodium Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Ceftriaxone Sodium Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Ceftriaxone Sodium Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Single Injection Image Figure 26. Global Single Injection Sales YoY Growth (2021-2032) & (MT) Figure 27. Compound Injection Image Figure 28. Global Compound Injection Sales YoY Growth (2021-2032) & (MT) Figure 29. Global Ceftriaxone Sodium Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Ceftriaxone Sodium Market Share by Application 2025 VS 2032 Figure 31. North America Ceftriaxone Sodium Sales Market Share in Volume by Application in 2025 Figure 32. North America Ceftriaxone Sodium Sales Market Share in Value by Application in 2025 Figure 33. Europe Ceftriaxone Sodium Sales Market Share in Volume by Application in 2025 Figure 34. Europe Ceftriaxone Sodium Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Ceftriaxone Sodium Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Ceftriaxone Sodium Sales Market Share in Value by Application in 2025 Figure 37. Latin America Ceftriaxone Sodium Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Ceftriaxone Sodium Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Ceftriaxone Sodium Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Ceftriaxone Sodium Sales Market Share in Value by Application in 2025 Figure 41. North America Ceftriaxone Sodium Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 42. North America Ceftriaxone Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Ceftriaxone Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Ceftriaxone Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ceftriaxone Sodium Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 46. Europe Ceftriaxone Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ceftriaxone Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Ceftriaxone Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ceftriaxone Sodium Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 50. Asia-Pacific Ceftriaxone Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ceftriaxone Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Ceftriaxone Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ceftriaxone Sodium Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 54. Latin America Ceftriaxone Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ceftriaxone Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Ceftriaxone Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ceftriaxone Sodium Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 58. Middle East and Africa Ceftriaxone Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ceftriaxone Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Ceftriaxone Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Ceftriaxone Sodium Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Ceftriaxone Sodium Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • ChP
  • USP
  • EP
Applications
  • Single Injection
  • Compound Injection
Companies covered
  • Shandong Ruiying
  • Qilu Antibiotics
  • Nectar Lifesciences
  • Kelun
  • United Laboratories
  • Aurobindo Pharma
  • Orchid Pharma
  • Medya Pharma
  • REYOUNG
  • LKPC
  • ACS Dobfar
  • NCPC
  • Dawnrays
  • Kopran

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ceftriaxone Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ceftriaxone Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ceftriaxone Sodium Market by Type
  6. 1.3.1 ChP
  7. 1.3.2 USP
  8. 1.3.3 EP
  9. 1.4 Global Ceftriaxone Sodium Market Size by Type
  10. 1.4.1 Global Ceftriaxone Sodium Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Ceftriaxone Sodium Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Ceftriaxone Sodium Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Ceftriaxone Sodium Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Ceftriaxone Sodium Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Ceftriaxone Sodium Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Ceftriaxone Sodium Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Ceftriaxone Sodium Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ceftriaxone Sodium Industry Trends
  2. 2.2 Ceftriaxone Sodium Industry Drivers
  3. 2.3 Ceftriaxone Sodium Industry Opportunities and Challenges
  4. 2.4 Ceftriaxone Sodium Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ceftriaxone Sodium Revenue (2021-2026)
  2. 3.2 Global Top Players by Ceftriaxone Sodium Sales (2021-2026)
  3. 3.3 Global Top Players by Ceftriaxone Sodium Price (2021-2026)
  4. 3.4 Global Ceftriaxone Sodium Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ceftriaxone Sodium Major Company Production Sites & Headquarters
  6. 3.6 Global Ceftriaxone Sodium Company, Product Type & Application
  7. 3.7 Global Ceftriaxone Sodium Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ceftriaxone Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ceftriaxone Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ceftriaxone Sodium Tier 1, Tier 2, and Tier 3
4 Ceftriaxone Sodium Regional Status and Outlook
  1. 4.1 Global Ceftriaxone Sodium Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ceftriaxone Sodium Historic Market Size by Region
  3. 4.2.1 Global Ceftriaxone Sodium Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ceftriaxone Sodium Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ceftriaxone Sodium Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ceftriaxone Sodium Forecasted Market Size by Region
  7. 4.3.1 Global Ceftriaxone Sodium Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ceftriaxone Sodium Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ceftriaxone Sodium Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ceftriaxone Sodium by Application
  1. 5.1 Ceftriaxone Sodium Market by Application
  2. 5.1.1 Single Injection
  3. 5.1.2 Compound Injection
  4. 5.2 Global Ceftriaxone Sodium Market Size by Application
  5. 5.2.1 Global Ceftriaxone Sodium Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Ceftriaxone Sodium Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Ceftriaxone Sodium Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Ceftriaxone Sodium Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Ceftriaxone Sodium Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Ceftriaxone Sodium Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Ceftriaxone Sodium Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Ceftriaxone Sodium Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shandong Ruiying
  2. 6.1.1 Shandong Ruiying Company Information
  3. 6.1.2 Shandong Ruiying Business Overview
  4. 6.1.3 Shandong Ruiying Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shandong Ruiying Ceftriaxone Sodium Product Portfolio
  6. 6.1.5 Shandong Ruiying Recent Developments
  7. 6.2 Qilu Antibiotics
  8. 6.2.1 Qilu Antibiotics Company Information
  9. 6.2.2 Qilu Antibiotics Business Overview
  10. 6.2.3 Qilu Antibiotics Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qilu Antibiotics Ceftriaxone Sodium Product Portfolio
  12. 6.2.5 Qilu Antibiotics Recent Developments
  13. 6.3 Nectar Lifesciences
  14. 6.3.1 Nectar Lifesciences Company Information
  15. 6.3.2 Nectar Lifesciences Business Overview
  16. 6.3.3 Nectar Lifesciences Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Nectar Lifesciences Ceftriaxone Sodium Product Portfolio
  18. 6.3.5 Nectar Lifesciences Recent Developments
  19. 6.4 Kelun
  20. 6.4.1 Kelun Company Information
  21. 6.4.2 Kelun Business Overview
  22. 6.4.3 Kelun Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kelun Ceftriaxone Sodium Product Portfolio
  24. 6.4.5 Kelun Recent Developments
  25. 6.5 United Laboratories
  26. 6.5.1 United Laboratories Company Information
  27. 6.5.2 United Laboratories Business Overview
  28. 6.5.3 United Laboratories Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 United Laboratories Ceftriaxone Sodium Product Portfolio
  30. 6.5.5 United Laboratories Recent Developments
  31. 6.6 Aurobindo Pharma
  32. 6.6.1 Aurobindo Pharma Company Information
  33. 6.6.2 Aurobindo Pharma Business Overview
  34. 6.6.3 Aurobindo Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Aurobindo Pharma Ceftriaxone Sodium Product Portfolio
  36. 6.6.5 Aurobindo Pharma Recent Developments
  37. 6.7 Orchid Pharma
  38. 6.7.1 Orchid Pharma Company Information
  39. 6.7.2 Orchid Pharma Business Overview
  40. 6.7.3 Orchid Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Orchid Pharma Ceftriaxone Sodium Product Portfolio
  42. 6.7.5 Orchid Pharma Recent Developments
  43. 6.8 Medya Pharma
  44. 6.8.1 Medya Pharma Company Information
  45. 6.8.2 Medya Pharma Business Overview
  46. 6.8.3 Medya Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Medya Pharma Ceftriaxone Sodium Product Portfolio
  48. 6.8.5 Medya Pharma Recent Developments
  49. 6.9 REYOUNG
  50. 6.9.1 REYOUNG Company Information
  51. 6.9.2 REYOUNG Business Overview
  52. 6.9.3 REYOUNG Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 REYOUNG Ceftriaxone Sodium Product Portfolio
  54. 6.9.5 REYOUNG Recent Developments
  55. 6.10 LKPC
  56. 6.10.1 LKPC Company Information
  57. 6.10.2 LKPC Business Overview
  58. 6.10.3 LKPC Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 LKPC Ceftriaxone Sodium Product Portfolio
  60. 6.10.5 LKPC Recent Developments
  61. 6.11 ACS Dobfar
  62. 6.11.1 ACS Dobfar Company Information
  63. 6.11.2 ACS Dobfar Business Overview
  64. 6.11.3 ACS Dobfar Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ACS Dobfar Ceftriaxone Sodium Product Portfolio
  66. 6.11.5 ACS Dobfar Recent Developments
  67. 6.12 NCPC
  68. 6.12.1 NCPC Company Information
  69. 6.12.2 NCPC Business Overview
  70. 6.12.3 NCPC Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 NCPC Ceftriaxone Sodium Product Portfolio
  72. 6.12.5 NCPC Recent Developments
  73. 6.13 Dawnrays
  74. 6.13.1 Dawnrays Company Information
  75. 6.13.2 Dawnrays Business Overview
  76. 6.13.3 Dawnrays Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Dawnrays Ceftriaxone Sodium Product Portfolio
  78. 6.13.5 Dawnrays Recent Developments
  79. 6.14 Kopran
  80. 6.14.1 Kopran Company Information
  81. 6.14.2 Kopran Business Overview
  82. 6.14.3 Kopran Ceftriaxone Sodium Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Kopran Ceftriaxone Sodium Product Portfolio
  84. 6.14.5 Kopran Recent Developments
7 North America by Country
  1. 7.1 North America Ceftriaxone Sodium Sales by Country
  2. 7.1.1 North America Ceftriaxone Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ceftriaxone Sodium Sales by Country (2021-2026)
  4. 7.1.3 North America Ceftriaxone Sodium Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ceftriaxone Sodium Market Size by Country
  6. 7.2.1 North America Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ceftriaxone Sodium Market Size by Country (2021-2026)
  8. 7.2.3 North America Ceftriaxone Sodium Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ceftriaxone Sodium Sales by Country
  2. 8.1.1 Europe Ceftriaxone Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ceftriaxone Sodium Sales by Country (2021-2026)
  4. 8.1.3 Europe Ceftriaxone Sodium Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ceftriaxone Sodium Market Size by Country
  6. 8.2.1 Europe Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ceftriaxone Sodium Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ceftriaxone Sodium Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ceftriaxone Sodium Sales by Country
  2. 9.1.1 Asia-Pacific Ceftriaxone Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ceftriaxone Sodium Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ceftriaxone Sodium Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ceftriaxone Sodium Market Size by Country
  6. 9.2.1 Asia-Pacific Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ceftriaxone Sodium Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ceftriaxone Sodium Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ceftriaxone Sodium Sales by Country
  2. 10.1.1 South America Ceftriaxone Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ceftriaxone Sodium Sales by Country (2021-2026)
  4. 10.1.3 South America Ceftriaxone Sodium Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ceftriaxone Sodium Market Size by Country
  6. 10.2.1 South America Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ceftriaxone Sodium Market Size by Country (2021-2026)
  8. 10.2.3 South America Ceftriaxone Sodium Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ceftriaxone Sodium Sales by Country
  2. 11.1.1 Middle East and Africa Ceftriaxone Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ceftriaxone Sodium Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ceftriaxone Sodium Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ceftriaxone Sodium Market Size by Country
  6. 11.2.1 Middle East and Africa Ceftriaxone Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ceftriaxone Sodium Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ceftriaxone Sodium Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ceftriaxone Sodium Value Chain Analysis
  2. 12.1.1 Ceftriaxone Sodium Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ceftriaxone Sodium Production Mode & Process
  7. 12.2 Ceftriaxone Sodium Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ceftriaxone Sodium Distributors
  10. 12.2.3 Ceftriaxone Sodium Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst